Assessment of various factors influencing esophageal pressure measurement. II. Significance of physiological factors in intraluminal manometry.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 7374097)

Published in Klin Wochenschr on March 17, 1980

Authors

T R Weihrauch, P Vallerius, H Alpers, K Ewe

Articles by these authors

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol (1995) 4.81

European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology (1984) 4.09

Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci (1981) 2.36

Endoscopic papillary dilation (EPD) for the treatment of common bile duct stones and papillary stenosis. Endoscopy (1983) 2.05

Olsalazine versus mesalazine in the treatment of mild to moderate ulcerative colitis. Aliment Pharmacol Ther (1998) 1.47

[Sterno-costo-clavicular hyperostosis: a hitherto undescribed entity (author's transl)]. Dtsch Med Wochenschr (1975) 1.28

Gastrointestinal pH profiles in patients with inflammatory bowel disease. Aliment Pharmacol Ther (1998) 1.17

Endoscopic papillary dilatation, a possible alternative to endoscopic papillotomy. Lancet (1982) 1.16

Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease. Gut (1983) 1.16

Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut (1985) 1.10

Fecal blood loss in patients with colonic polyps: a comparison of measurements with 51chromium-labeled erythrocytes and with the Haemoccult test. Gastroenterology (1982) 1.09

The inhibition by dopamine of cholinergic transmission in the isolated guinea-pig ileum. Mediation through alpha-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.95

Mechanical gallstone lithotripsy in the common bile duct--in-vitro and in-vivo experience. Endoscopy (1983) 0.95

Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand J Gastroenterol (1990) 0.95

Cerebral toxicity of penicillins in relation to their hydrophobic character. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.94

Factitious diarrhoea. Clin Gastroenterol (1986) 0.93

Alteration of esophageal peristalsis by pentagastrin in patients with diffuse esophageal spasm. Scand J Gastroenterol (1975) 0.90

Gastro-oesophageal reflux--pathogenesis and clinical implications. Eur J Pediatr (1985) 0.89

Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group. Eur J Gastroenterol Hepatol (1996) 0.88

n-3 fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci (1996) 0.87

Bacteremia after proctoscopy and hemorrhoidal injection sclerotherapy. Dis Colon Rectum (1981) 0.87

[The early recurrence of Crohn's disease after "curative" ileocecal resection. A prospective endoscopic and histological study]. Dtsch Med Wochenschr (1990) 0.87

Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease. Dig Dis Sci (1985) 0.86

Is abdominal compression a useful stimulation test for analysis of lower esophageal sphincter function? Dig Dis Sci (1984) 0.86

Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group. Gut (1998) 0.86

[Endoscopic papillary dilatation: an alternative to papillotomy? (author's transl)]. Dtsch Med Wochenschr (1982) 0.85

[Spermatogram evaluation in cases with Crohn disease]. Andrologia (1981) 0.84

[The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon]. Fortschr Med (1990) 0.84

Effect of the calcium antagonists nifedipine, nitrendipine, nimodipine and nisoldipine on oesophageal motility in man. Eur J Clin Pharmacol (1991) 0.84

[Enteropathic spondylarthritis in chronic inflammatory bowel diseases: prevalence, manifestation pattern and HLA association]. Med Klin (Munich) (1996) 0.84

Antibodies to cytoskeletal proteins in patients with Crohn's disease. Eur J Clin Invest (1990) 0.84

Letter: Prevention of post-transfusion hepatitis. Lancet (1974) 0.83

Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud's disease. Br J Dermatol (1982) 0.83

[Resorption and secretion of calcium in the human jejunum]. Klin Wochenschr (1968) 0.83

[Course of intraluminal esophageal pressure after laryngectomy (author's transl)]. Laryngol Rhinol Otol (Stuttg) (1977) 0.83

Rational pharmacotherapy of gastrointestinal motility disorders. Eur J Pediatr (1989) 0.83

Endoscopic balloon tamponade for conservative management of severe hemorrhage following endoscopic sphincterotomy. Z Gastroenterol (1984) 0.82

[Extent of drug compliance in Crohn disease patients--study of a special ambulatory care unit of a university clinic]. Z Gastroenterol (1984) 0.82

[Significance of lipophilia for the neurotoxicity of penicillins]. Verh Dtsch Ges Inn Med (1974) 0.82

[The effect of a diphenolic laxative (Bisacodyl) on water- and electrolyte transport in the human colon (author's transl)]. Klin Wochenschr (1974) 0.81

Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev (2003) 0.81

Macroamylasaemia after treatment with hydroxyethyl starch. Eur J Clin Invest (1977) 0.81

Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1. Arzneimittelforschung (1985) 0.81

Nitroglycerine dilatation of sphincter of Oddi for endoscopic removal of bileduct stones. Lancet (1984) 0.81

Drugs increasing gastrointestinal motility. Pharmacology (1982) 0.80

[Pancreatitis associated with 5-aminosalicylic acid]. Dtsch Med Wochenschr (1991) 0.80

IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases. Eur J Gastroenterol Hepatol (2000) 0.80

Evaluation of the effect of domperidone on human oesophageal and gastroduodenal motility by intraluminal manometry. Postgrad Med J (1979) 0.79

Corticosteroids for maintaining remission of Crohn's disease. Cochrane Database Syst Rev (2001) 0.79

Treatment of active Crohn's disease with an oral slow-release budesonide formulation. Am J Gastroenterol (1993) 0.79

A new electronic transducer system for gastrointestinal pressure studies. Med Prog Technol (1977) 0.79

[Intraluminal manometry by means of a new electronic measuring device]. Verh Dtsch Ges Inn Med (1976) 0.79

The physiological basis of laxative action. Pharmacology (1980) 0.79

Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group. Z Gastroenterol (1995) 0.79

Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group. Hepatogastroenterology (1997) 0.78

Pentazocine hampers bile flow. Lancet (1985) 0.78

[(Quality of semen in patients with Crohn's disease) ]. Z Gastroenterol (1982) 0.77

Assessment of various factors influencing esophageal pressure measurement. I. Significance of methodical factors in intraluminal manometry. Klin Wochenschr (1980) 0.77

Calcium and magnesium transport and influence of 1,25-dihydroxyvitamin D3. In vivo perfusion study at the colon of the rat. Digestion (1987) 0.77

Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working group. Z Gastroenterol (1999) 0.77

Influence of loperamide and loperamide oxide on the anal sphincter. A manometric study. Dis Colon Rectum (1992) 0.76

Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis. Klin Wochenschr (1978) 0.75

[Neurotoxicity of carbenicillin (author's transl)]. Klin Wochenschr (1974) 0.75

Investigation of the sphincter of Oddi before, immediately after and six weeks after endoscopic papillotomy. Endoscopy (1986) 0.75

[Opium drops in diarrhea caused by Crohn disease]. Dtsch Med Wochenschr (1997) 0.75

Fecal alpha 1-antitrypsin in newborn infants. J Pediatr Gastroenterol Nutr (1997) 0.75

Effect of intravenous diazepam on human lower oesophageal sphincter pressure under controlled double blind crossover conditions. Gut (1979) 0.75

[Manometric study of esophageal involvement in progressive systemic sclerosis (author's transl)]. Arch Dermatol Res (1975) 0.75

[Prophylactic measures in gastroenterology]. Verh Dtsch Ges Inn Med (1980) 0.75

[Ulcerative colitis. Current questions in clinic and therapy]. Internist (Berl) (1981) 0.75

[Endoscopic papillary and bile duct manometry in evaluating the function of Vater's papilla. Studies on patients with cholecystolithiasis]. Schweiz Rundsch Med Prax (1984) 0.75

[Preventive measures in gastroenterology]. Internist (Berl) (1981) 0.75

[Pathogenesis of chronic inflammatory bowel diseases]. Z Gastroenterol Verh (1983) 0.75

Postprandial cholylglycine serum concentration and extent of ileal inflammation or resection in Crohn's disease. Digestion (1986) 0.75

[Precancerous conditions in the upper gastrointestinal tract. Diagnosis and monitoring]. Dtsch Med Wochenschr (1985) 0.75

[Crohn disease: when conservative, when surgical treatment?]. Dtsch Med Wochenschr (1984) 0.75

[Effectiveness of Azulfidine/Salazopyrin in the postoperative prevention of recurrence in Crohn disease]. Z Gastroenterol Verh (1981) 0.75

[Colorectal precancerous states. Diagnosis and monitoring]. Dtsch Med Wochenschr (1985) 0.75

[Amebic colitis - differential diagnosis of ulcerative colitis and Crohn disease]. Z Gastroenterol (1984) 0.75

[Intestinal loss syndromes]. Z Gastroenterol Verh (1979) 0.75

Effect of the artificially elevated common bile duct pressure on the motor activity and function of the papilla of Vater. A study by endoscopic manometry. Digestion (1985) 0.75

The effect of cathartic agents on transmucosal electrical potential difference in the human rectum. Klin Wochenschr (1980) 0.75

[Determination of intestinal inflammatory activity in Crohn disease using alpha 1-antitrypsin]. Dtsch Med Wochenschr (1985) 0.75

[Surgical and internal medicine therapy study of the postoperative prevention of recurrence in Crohn's disease - completion of a partly randomized study]. Verh Dtsch Ges Inn Med (1980) 0.75

[Therapy of toxic colonic dilatation]. Dtsch Med Wochenschr (1980) 0.75

[Radical operation and recurrence prevention with azulfidine in Crohn disease: a prospective multicenter study--initial results]. Langenbecks Arch Chir (1984) 0.75

[Endoscopic gallstone extraction through the intact bile duct sphincter after drug-induced dilatation of Vater's ampulla]. Schweiz Rundsch Med Prax (1986) 0.75

Effect of rhein on the transport of electrolytes, water, and carbohydrates in the human jejunum and colon. Pharmacology (1980) 0.75

[ERCP using a new contrast catheter movable in all directions. An aid in typical ERCP problems]. Schweiz Rundsch Med Prax (1984) 0.75

[Indications for gastroscopy]. Lebensversicher Med (1980) 0.75

[Endoscopic assessment of esophageal variceal pressure]. Schweiz Rundsch Med Prax (1984) 0.75

Computed tomography to predict hardness of bileduct stones before endoscopic lithotripsy. Lancet (1984) 0.75

ERCP using a special catheter with external steering. A reliable aid in typical ERCP problems. Endoscopy (1985) 0.75

[Balloon tamponade in acute hemorrhage following endoscopic papillotomy]. Schweiz Rundsch Med Prax (1986) 0.75

[Biopsy of small intestine in Crohn's disease of terminal ileum and/or colon; a histoligical and electron microscopical study (author's transl)]. Z Gastroenterol (1979) 0.75